<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01023893</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-0062-201</org_study_id>
    <nct_id>NCT01023893</nct_id>
  </id_info>
  <brief_title>Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1)</brief_title>
  <acronym>BEAM-1</acronym>
  <official_title>Clinical Diagnostic Evaluation Study of Blood Viscosity, End-Stage Renal Disease, And Mortality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProMetrics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ProMetrics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, real-time observational study of hemodialysis patients treated with
      erythropoiesis-stimulating agents (ESA) to currently recommended Hgb targets. Subjects will
      be evaluated dynamically for their blood viscosity status at the beginning and end of the
      dialysis treatment, and followed prospectively to assess outcomes. Blood specimens will be
      collected via the subject's hemodialysis port pre- and post-hemodialysis per study assessment
      visit. Blood will be analyzed at a designated laboratory facility for viscosity over a
      comprehensive range of shear rates and tested for intradialytic surges in blood viscosity.
      Subjects will be followed for 48 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access thrombosis</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Renal Replacement Therapy</condition>
  <arm_group>
    <arm_group_label>End-stage renal disease</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Dialysis clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  On hemodialysis &gt; 3 months

          -  On ESA treatment &gt; 3 months

          -  Mean Hgb 11 g/dL - 12 g/dL (based on at least 3 Hgb results during the previous 8
             weeks)

          -  Latest Hgb 10.5 g/dL - 12.5 g/dL (measured within 1 week of study)

        Exclusion Criteria:

          -  Inability or unwillingness to provide informed consent

          -  Large variability in interdialytic weight gain (&gt;2 kg difference between low and high
             weight gain over last month)

          -  More than 1 missed dialysis treatments in past month

          -  Recent bleeding

          -  Blood transfusion within 1 month

          -  Hematologic disease other than anemia

          -  Active inflammatory disease

          -  Active infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Vaisman S, Kensey K, Cho YI. Effect of hemodialysis on whole blood viscosity. Int J Artif Organs. 2009 Jun;32(6):329-35.</citation>
    <PMID>19670184</PMID>
  </reference>
  <reference>
    <citation>Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997 Jan;96(1):168-73.</citation>
    <PMID>9012704</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <last_update_submitted>December 1, 2009</last_update_submitted>
  <last_update_submitted_qc>December 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Daniel Cho, VP Lab Services</name_title>
    <organization>ProMetrics</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

